Itm Isotope Technologies Munich Se

Itm Isotope Technologies Munich Se company information, Employees & Contact Information

PASSION FOR PRECISION. ITM, a leading radiopharmaceutical biotech company, is dedicated to providing a new generation of radiopharmaceutical therapeutics and diagnostics for hard-to-treat tumors. We aim to meet the needs of cancer patients, clinicians and our partners through excellence in development, production and global supply. With improved patient benefit as the driving principle for all we do, ITM advances a broad precision oncology pipeline, including multiple Phase 3 studies, combining the company’s high-quality radioisotopes with a range of targeting molecules. By leveraging our two decades of pioneering radiopharma expertise, central industry position and established global network, ITM strives to provide patients with more effective targeted treatment to improve clinical outcome and quality of life. For more information please visit: www.itm-radiopharma.com. Please see our Community Guidelines: https://isotope-technologies-munich.com/service/community-guidelines

Company Details

Employees
559
Founded
-
Address
Lichtenbergstrasse 1, Garching Near Munich,bavaria 85748,germany
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
itm.ag
HQ
Garching near Munich, Bavaria
Looking for a particular Itm Isotope Technologies Munich Se employee's phone or email?

Itm Isotope Technologies Munich Se Questions

News

ITM Appoints Annette Breunig as Chief People Officer - GlobeNewswire

ITM Appoints Annette Breunig as Chief People Officer GlobeNewswire

ITM Power Plc (LON:ITM) is largely controlled by institutional shareholders who own 61% of the company - Yahoo Finance

ITM Power Plc (LON:ITM) is largely controlled by institutional shareholders who own 61% of the company Yahoo Finance

Longtime manufacturer ITM's lead radiotherapy outperforms standard of care in phase 3 neuroendocrine tumor trial - Fierce Biotech

Longtime manufacturer ITM's lead radiotherapy outperforms standard of care in phase 3 neuroendocrine tumor trial Fierce Biotech

ITM to Announce Phase 3 COMPETE Trial Post Hoc Subgroup - GlobeNewswire

ITM to Announce Phase 3 COMPETE Trial Post Hoc Subgroup GlobeNewswire

Why Investors Shouldn't Be Surprised By ITM Power Plc's (LON:ITM) 25% Share Price Surge - simplywall.st

Why Investors Shouldn't Be Surprised By ITM Power Plc's (LON:ITM) 25% Share Price Surge simplywall.st

ITM secures $204.6m to advance radiopharmaceutical pipeline - Pharmaceutical Technology

ITM secures $204.6m to advance radiopharmaceutical pipeline Pharmaceutical Technology

ITM Power Announces Joint Venture with Linde AG and £38M Strategic Investment - Fuel Cells Works

ITM Power Announces Joint Venture with Linde AG and £38M Strategic Investment Fuel Cells Works

ITM Power shares advance on FEED contract - Proactive Investors

ITM Power shares advance on FEED contract Proactive Investors

ITM Announces Completion of Conversion into SE - Business Wire

ITM Announces Completion of Conversion into SE Business Wire

Sheffield’s ITM Power signs hydrogen electrolyser deal with RWE - Energy Voice

Sheffield’s ITM Power signs hydrogen electrolyser deal with RWE Energy Voice

ITM to Present New Subgroup Analysis Data from the COMPETE - GlobeNewswire

ITM to Present New Subgroup Analysis Data from the COMPETE GlobeNewswire

Hydrogen sector: ITM, or Ceres? There's one clear winner, says investment bank - Proactive Investors

Hydrogen sector: ITM, or Ceres? There's one clear winner, says investment bank Proactive Investors

ITM to Participate in Upcoming Investor Conferences - Yahoo! Finance Singapore

ITM to Participate in Upcoming Investor Conferences Yahoo! Finance Singapore

ITM to Present COMPETE Dosimetry Data and Host Satellite Symposium at EANM 2025 - GlobeNewswire

ITM to Present COMPETE Dosimetry Data and Host Satellite Symposium at EANM 2025 GlobeNewswire

ITM to Present at the Oppenheimer Annual Targeted Radiopharmaceutical Therapies in Oncology Summit - GlobeNewswire

ITM to Present at the Oppenheimer Annual Targeted Radiopharmaceutical Therapies in Oncology Summit GlobeNewswire

ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds - GlobeNewswire

ITM Secures Up to $262.5m in Non-dilutive Debt Financing with Blue Owl Managed Funds GlobeNewswire

ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium - GlobeNewswire

ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium GlobeNewswire

ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 - GlobeNewswire

ITM and Alpha-9 Oncology Enter Into Supply Agreement for Therapeutic Medical Radioisotope Actinium-225 GlobeNewswire

ITM Appoints Dr. Celine Wilke as Chief Medical Officer - GlobeNewswire

ITM Appoints Dr. Celine Wilke as Chief Medical Officer GlobeNewswire

ITM Announces Updates to Commercial Leadership - GlobeNewswire

ITM Announces Updates to Commercial Leadership GlobeNewswire

ITM targets US approval for radiopharmaceutical after Phase III readout - Pharmaceutical Technology

ITM targets US approval for radiopharmaceutical after Phase III readout Pharmaceutical Technology

Options: What is ATM, ITM, OTM? - India Infoline

Options: What is ATM, ITM, OTM? India Infoline

ITM gets equity to launch Phase III lead radiopharmaceutical ITM-11 - European Biotechnology Magazine

ITM gets equity to launch Phase III lead radiopharmaceutical ITM-11 European Biotechnology Magazine

ITM Raises €188m to Enhance Radiopharmaceutical Pipeline - GlobeNewswire

ITM Raises €188m to Enhance Radiopharmaceutical Pipeline GlobeNewswire

FDA Grants Fast Track Designation to ITM-11 for Gastroenteropancreatic Neuroendocrine Tumors - OncLive

FDA Grants Fast Track Designation to ITM-11 for Gastroenteropancreatic Neuroendocrine Tumors OncLive

ITM-11 succeeds in phase 3: The first big win for radiopharma? - Labiotech.eu

ITM-11 succeeds in phase 3: The first big win for radiopharma? Labiotech.eu

2025 International Track Meet (ITM) - Athletics New Zealand

2025 International Track Meet (ITM) Athletics New Zealand

ITM Announces Positive Topline Results of Phase 3 COMPETE - GlobeNewswire

ITM Announces Positive Topline Results of Phase 3 COMPETE GlobeNewswire

Phase 0 trials/ Intra-Target-Microdosing (ITM) and the lung: a review - BMC Pulmonary Medicine

Phase 0 trials/ Intra-Target-Microdosing (ITM) and the lung: a review BMC Pulmonary Medicine

ITM fleshes out data for Phase III radiopharma success in neuroendocrine tumours - FirstWord Pharma

ITM fleshes out data for Phase III radiopharma success in neuroendocrine tumours FirstWord Pharma

ITM Power Stock Down 11% But Insiders Still In UK£220k Profit - Yahoo Finance

ITM Power Stock Down 11% But Insiders Still In UK£220k Profit Yahoo Finance

Germany’s ITM receives material license to produce Lu-177 - American Nuclear Society

Germany’s ITM receives material license to produce Lu-177 American Nuclear Society

Reed Smith advises biotech company ITM Isotope Technologies Munich SE on €255 million financing led by Temasek - Reed Smith LLP

Reed Smith advises biotech company ITM Isotope Technologies Munich SE on €255 million financing led by Temasek Reed Smith LLP

Itm Power Share News (ITM) - London South East

Itm Power Share News (ITM) London South East

Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225 - GlobeNewswire

Cellectar Biosciences and ITM Enter Supply Agreement for GMP-Grade Actinium-225 GlobeNewswire

Ionospheric, Thermospheric, Mesospheric (ITM) Physics Laboratory - NASA (.gov)

Ionospheric, Thermospheric, Mesospheric (ITM) Physics Laboratory NASA (.gov)

ITM follows €255M investment round by opening new facility - Labiotech.eu

ITM follows €255M investment round by opening new facility Labiotech.eu

ITM Power Full Year 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

ITM Power Full Year 2025 Earnings: Revenues Beat Expectations, EPS Lags Yahoo Finance

New radiopharmaceutical heading to the FDA after Phase 3 win - statnews.com

New radiopharmaceutical heading to the FDA after Phase 3 win statnews.com

German biotech firm brings US headquarters to Route 1 corridor - Central New Jersey News

German biotech firm brings US headquarters to Route 1 corridor Central New Jersey News

ITM, TUM, and TUM University Hospital Sign New Framework - GlobeNewswire

ITM, TUM, and TUM University Hospital Sign New Framework GlobeNewswire

ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer - GlobeNewswire

ITM Appoints Dr. Danielle Meyrick as Chief Medical Officer GlobeNewswire

ITM and GBTA publish ground transport guide - The Business Travel Magazine

ITM and GBTA publish ground transport guide The Business Travel Magazine

ITM Power to deliver FEED for UK hydrogen project using its 5 MW electrolyzer solution - Offshore Energy

ITM Power to deliver FEED for UK hydrogen project using its 5 MW electrolyzer solution Offshore Energy

ITM Power Appoints Jürgen Nowicki as Non-Executive Chair - Fuel Cells Works

ITM Power Appoints Jürgen Nowicki as Non-Executive Chair Fuel Cells Works

ITM raises €188M for radiopharmaceutical pipeline - BioWorld MedTech

ITM raises €188M for radiopharmaceutical pipeline BioWorld MedTech

Heberlein Technology AG, Supplier Of Air Interlacing And Air Texturing Jets, On Display At ITM 2024 - Textile World

Heberlein Technology AG, Supplier Of Air Interlacing And Air Texturing Jets, On Display At ITM 2024 Textile World

ITM and Alpha-9 Oncology Announce Global Supply Agreement - GlobeNewswire

ITM and Alpha-9 Oncology Announce Global Supply Agreement GlobeNewswire

ITM Appoints Roger Estafanos as U.S. General Manager and - GlobeNewswire

ITM Appoints Roger Estafanos as U.S. General Manager and GlobeNewswire

ITM Receives Equity Investment of EUR 25 Million from Strategic Partner Grand Pharma - Business Wire

ITM Receives Equity Investment of EUR 25 Million from Strategic Partner Grand Pharma Business Wire

ITM at Minexpo 2024: innovation, customised solutions and sustainability - GlobeNewswire

ITM at Minexpo 2024: innovation, customised solutions and sustainability GlobeNewswire

ITM unveils 50MW PEM electrolyser priced at €50m that will be 'cheaper than Chinese alkaline machines in Europe' - Hydrogen Insight

ITM unveils 50MW PEM electrolyser priced at €50m that will be 'cheaper than Chinese alkaline machines in Europe' Hydrogen Insight

ITM Appoints Dr. Andrew Cavey as CEO to Lead Organization in its Next Stage of Growth - GlobeNewswire

ITM Appoints Dr. Andrew Cavey as CEO to Lead Organization in its Next Stage of Growth GlobeNewswire

ITM and MTTI Sign Clinical Supply Agreement for n.c.a. Lutetium-177 - Business Wire

ITM and MTTI Sign Clinical Supply Agreement for n.c.a. Lutetium-177 Business Wire

ITM's Subsidiary ITG Receives Drug Approval for EndolucinBeta® - Biotech Newswire

ITM's Subsidiary ITG Receives Drug Approval for EndolucinBeta® Biotech Newswire

Snam Focuses on Green Hydrogen Technologies: Partnership launched with British ITM Power, one of the major global manufacturers of electrolysers - Fuel Cells Works

Snam Focuses on Green Hydrogen Technologies: Partnership launched with British ITM Power, one of the major global manufacturers of electrolysers Fuel Cells Works

ITM Power to supply electrolyzer for MorGen Energy’s 20 MW hydrogen project in Wales - Offshore Energy

ITM Power to supply electrolyzer for MorGen Energy’s 20 MW hydrogen project in Wales Offshore Energy

ITM Appoints Dr. Sebastian Marx as Chief Business Officer and Member of Executive Board - GlobeNewswire

ITM Appoints Dr. Sebastian Marx as Chief Business Officer and Member of Executive Board GlobeNewswire

ITM selected to supply more than 300MW of electrolysers to produce green hydrogen for use in Asian power plant - Hydrogen Insight

ITM selected to supply more than 300MW of electrolysers to produce green hydrogen for use in Asian power plant Hydrogen Insight

ITM Isotope Technologies Munich Receives €33M Equity Funding - FinSMEs

ITM Isotope Technologies Munich Receives €33M Equity Funding FinSMEs

Uniper selects ITM Power electrolysers for 120MW UK green hydrogen plant - H2 View

Uniper selects ITM Power electrolysers for 120MW UK green hydrogen plant H2 View

ITM to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Oklahoma City News - The Oklahoman - FinancialContent

ITM to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Oklahoma City News - The Oklahoman FinancialContent

Oklahoma City News - The Oklahoman - FinancialContent

Oklahoma City News - The Oklahoman FinancialContent

ITM Isotope Technologies Munich to Present at the 40th Annual J.P. Morgan Healthcare Conference - FinancialContent

ITM Isotope Technologies Munich to Present at the 40th Annual J.P. Morgan Healthcare Conference FinancialContent

Portland Investment Counsel Inc. Leads Investment in Telix Pharmaceuticals Limited via Private Placement - GlobeNewswire

Portland Investment Counsel Inc. Leads Investment in Telix Pharmaceuticals Limited via Private Placement GlobeNewswire

ITM Power – Contract for three NEPTUNE V Electrolyzers - Hydrogen Central

ITM Power – Contract for three NEPTUNE V Electrolyzers Hydrogen Central

ITM Power stock price drops after disappointing forward guidance - City AM

ITM Power stock price drops after disappointing forward guidance City AM

Uniper selects ITM Power to supply electrolysers for Humber H2ub® (Green) project - Uniper

Uniper selects ITM Power to supply electrolysers for Humber H2ub® (Green) project Uniper

ITM Power looking for consistency - Investors' Chronicle

ITM Power looking for consistency Investors' Chronicle

Stoll knitted shoe uppers attract attention at ITM - Knitting Industry

Stoll knitted shoe uppers attract attention at ITM Knitting Industry

ITM continues to focus on capacity building - Instituut voor Tropische Geneeskunde

ITM continues to focus on capacity building Instituut voor Tropische Geneeskunde

ITM Power: Shares in green hydrogen specialist skyrocket - City AM

ITM Power: Shares in green hydrogen specialist skyrocket City AM

ITM Power plc (ITM.L) stock price, news, quote and history - Yahoo! Finance UK

ITM Power plc (ITM.L) stock price, news, quote and history Yahoo! Finance UK

Saurer to present new machines and technology at ITM 2024 - Textile Today

Saurer to present new machines and technology at ITM 2024 Textile Today

Troubled hydrogen electrolyser maker ITM expands factory space by 62% in bid to 'debottleneck' production - Hydrogen Insight

Troubled hydrogen electrolyser maker ITM expands factory space by 62% in bid to 'debottleneck' production Hydrogen Insight

2024 ITM Taupō Super400 - Supercars

2024 ITM Taupō Super400 Supercars

ITM Power shares soar as green hydrogen specialist hikes guidance - business-live.co.uk

ITM Power shares soar as green hydrogen specialist hikes guidance business-live.co.uk

Still in pennies, could the ITM Power share price hit £6 again? - Fool UK

Still in pennies, could the ITM Power share price hit £6 again? Fool UK

Review: ITM X-One Carbon Handlebar - Road.cc

Review: ITM X-One Carbon Handlebar Road.cc

UGC seeks details from Raipur’s ITM varsity - Mumbai Mirror

UGC seeks details from Raipur’s ITM varsity Mumbai Mirror

ITM Power PLC Share Price - ITM, RNS News, Articles, Quotes, & Charts (LON:ITM) - Proactive Investors

ITM Power PLC Share Price - ITM, RNS News, Articles, Quotes, & Charts (LON:ITM) Proactive Investors

Prof MS Swaminathan receives D Lit degree by ITM University - The New Indian Express

Prof MS Swaminathan receives D Lit degree by ITM University The New Indian Express

ITM Group of Institutions: Courses, Eligibility, Fees and Admission - Shiksha

ITM Group of Institutions: Courses, Eligibility, Fees and Admission Shiksha

The ITM Fishing Show hooks in a new time slot on Prime with revived programme - Stuff

The ITM Fishing Show hooks in a new time slot on Prime with revived programme Stuff

ITM SLS Baroda University Admission 2025: Eligibility, Fee, Application & Selection Criteria - Shiksha

ITM SLS Baroda University Admission 2025: Eligibility, Fee, Application & Selection Criteria Shiksha

ITM SLS Baroda University: Courses, Fees, Admissions 2025, Placements - Shiksha

ITM SLS Baroda University: Courses, Fees, Admissions 2025, Placements Shiksha

ITM Business School Navi Mumbai: Courses, Fees, Admission 2025, Placements, Cutoffs - Shiksha

ITM Business School Navi Mumbai: Courses, Fees, Admission 2025, Placements, Cutoffs Shiksha

ITM Business School Navi Mumbai Course Admissions 2025: Fees, Eligibility, Dates, Selection Criteria - Shiksha

ITM Business School Navi Mumbai Course Admissions 2025: Fees, Eligibility, Dates, Selection Criteria Shiksha

Top Itm Isotope Technologies Munich Se Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant